- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07463755
Low-Fidelity Driving Simulator Training in Parkinson's Disease.
Low-Fidelity Driving Simulator Training and Driving Outcomes in Parkinson's Disease: A Pilot Randomized Control Study
The goal of this clinical trial is to learn if low-fidelity driving simulator training works to improve cognitive performance, driving behavior, and driving aptitude in individuals with Parkinson's disease. The main questions it aims to answer are:
- Does low-fidelity driving simulator training improve cognitive performance?
- Does low-fidelity driving simulator training improve driving performance?
- Does low-fidelity driving simulator training improve driving aptitude?
Researchers will compare driving simulator training to no-training (waitlist control group) to see if the low-fidelity driving simulator is effective in individuals with Parkinson's disease.
Participants will:
- Undergo 10 sessions of driving simulator training or be placed in the no-training group.
- Training group participants will visit the driving simulator lab 2-3 times a week for 4 weeks for training.
- Paper-based tests and driving simulator tests will be done before and after 10 sessions of training (or a waiting period).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Abiodun E Akinwuntan, Ph.D.
- Phone Number: 711 TTY 913-588-5235
- Email: aakinwuntan@kumc.edu
Study Locations
-
-
Kansas
-
Kansas City, Kansas, United States, 66103
- Mobility and Falls Lab
-
Contact:
- Samuel K Durairaj, MPT
- Phone Number: 913-326-7999
- Email: sdurairaj@kumc.edu
-
Principal Investigator:
- Abiodun E Akinwuntan, Ph.D.
-
Sub-Investigator:
- Hannes Devos, PhD
-
Sub-Investigator:
- Samuel K Durairaj, MPT
-
Sub-Investigator:
- Kelly Lyons, PhD
-
Sub-Investigator:
- Jianghua He, PhD
-
Sub-Investigator:
- Linda D'Silva, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Individuals with Parkinson's disease diagnosed by a movement disorder specialist.
- Diagnosis of PD was based on the UK Brain Bank Diagnostic Criteria.
- Hoehn and Yahr stage 1 to 3 in the medication ON state with no troublesome dyskinesia.
- Minimum binocular acuity of 20/40 or better at least in one eye according to the Kansas DMV statutes.
- Montreal Cognitive Assessment (MoCA) ≥ 20.
- Ambulates independently with or without walking aids.
- Possess a valid driver's license.
Exclusion Criteria:
- Any concomitant neurological comorbidity, such as stroke, traumatic brain injury, or multiple sclerosis, that would hinder driving.
- Atypical forms of Parkinsonism
- History of substance abuse in the last 10 years.
- History of uncontrolled psychiatric problems
- Undergone deep brain stimulation or focused ultrasound treatment
- Uncontrolled diabetes mellitus
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Training
Participants in the training arm will undergo 10 sessions of low-fidelity driving simulator training targeting different skills related to driving.
|
Participants in the treatment group will undergo 10 sessions of training on a low-fidelity driving simulator.
Each session will last approximately 45-60 minutes.
There will be 2-3 sessions each week for 4 weeks.
|
|
No Intervention: Waitlist control
The waitlist control group will not undergo any training during the study period.
They will be offered a short training after the study is complete.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Driving performance - Standard Lane Deviation Position
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
SDLP refers to the mean Lane position of the driver's vehicle to the roadway centerline (defined as zero).
The center of the vehicle is the reference point.
Positive values indicate lane positions on the right side of the road; negative values indicate left.
Default roadway lane widths are 12 ft (3.66 m) across; therefore, values close to 6 ft (1.83 m) indicate positioning near the center of a lane.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Driving aptitude - The Adelaide Driving Self-Efficacy Scale
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
The Adelaide Driving Self-Efficacy Scale is a self-reported assessment of participants' beliefs in their capability to organize and execute actions towards safe driving.
It is a 12-item questionnaire that measures an individual's self-perceived confidence in performing various driving-related activities, such as driving in heavy traffic or at night.
It uses a 0 (not confident at all) to 10 (completely confident) rating scale for each activity, with total scores indicating overall driving confidence.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive performance - Montreal Cognitive Assessment
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
The Montreal Cognitive Assessment is a brief screening tool used to detect mild cognitive impairment and early dementia. It evaluates multiple cognitive domains, including attention, executive function, memory, language, visuospatial skills, abstraction, calculation, and orientation. Total score is 30 points. > or = 26 ---- Normal 18 to 25 ----- Mild cognitive impairment |
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Cognitive performance - Dot cancellation test errors
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
The Dot Cancellation Test is a neuropsychological evaluation tool used to assess focus, attention, visual scanning, and occasionally motor speed or neglect.
It is also referred to as the Cancellation Test or Visual Cancellation Task.
The participant is given a page with a random cluster of dots and instructed to cross out (cancel) a particular type of cluster of dots.
The investigator calculates the time taken and the number of errors committed by the participant.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Cognitive performance - Rey-Osterrieth Complex Figure Copy
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
The Rey-Rey-Osterrieth Complex Figure Copy Test is a neuropsychological tool used to assess visuospatial constructional ability, planning, and organizational skills.
The individual is asked to copy a complex geometric figure, and their drawing is scored based on the accuracy and placement of 18 specific design components.
The score ranges from 0 to 36.
A higher score indicates better performance.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Cognitive performance - Trail Making Tests A & B
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
The Trail Making Test is a paper-and-pencil assessment used to measure attention, processing speed, and executive function.
It has two parts: TMT-A, where individuals connect numbers in sequence (1-25), primarily tests visual scanning and processing speed.
TMT-B requires alternating between numbers and letters in order (1-A-2-B, etc.), placing greater demand on cognitive flexibility and set-shifting.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Cognitive performance - Snellgrove Maze Task
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
The Snellgrove Maze Task is a paper-and-pencil test designed to screen for cognitive and executive function impairments that may affect safe driving.
The participant is asked to navigate a complex maze as quickly and accurately as possible without lifting the pencil from the page.
Performance is measured by time to completion and number of errors (e.g., wrong turns, dead ends).
Longer times and higher error counts are associated with poorer executive function.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Cognitive performance - Stroke Driver Screening Assessment (US version)
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
The Stroke Driver Screening Assessment (SDSA) is a standardized battery of paper-and-pencil tests developed to predict fitness to drive after stroke or other brain injuries.
It includes subtests such as Dot Cancellation (visual attention), Directions Test (visuospatial and executive skills), Road Sign Recognition (memory and comprehension), and Compass Test (spatial orientation).
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Driving performance - Divided attention
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
Divided attention in simulator evaluations refers to a driver's ability to manage driving tasks while simultaneously responding to secondary demands, such as detecting shapes.
Performance is typically measured by reaction time, accuracy of responses, and driving stability (lane keeping, speed control) during the dual-task condition.
Poor divided attention scores suggest reduced cognitive flexibility and higher crash risk.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Driving performance - Time to Collision
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
Time to Collision is a safety metric in driving simulator evaluations that estimates how long it would take for a driver to collide with a lead vehicle or hazard if both maintained their current speed and trajectory.
A shorter TTC indicates less available reaction time and a higher crash risk.
Critical thresholds (often ≤ 1.5-2.0
seconds) are used to identify unsafe or delayed responses.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Driving Performance - Navigating Intersections
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
Navigating intersections in simulator evaluations assesses a driver's ability to manage visual scanning, hazard perception, decision-making, and vehicle control while navigating an intersection.
The performance is measured by gap acceptance.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Driving performance - Complex Brake Reaction Time
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
Complex Brake Reaction Time in simulator evaluations measures how quickly a driver can detect an unexpected hazard, process the situation, and apply the brake in a more demanding context.
Longer Complex Brake Reaction Time indicates delayed hazard response and higher crash risk.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Driving performance - Driver errors.
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
Driver mistakes, such as the number of collisions, the number of lane positioning errors, total number of tickets, will be recorded during the simulator drive assessment.
Higher scores indicate poor driving performance.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Driving performance - The Test Ride for Investigating Practical Fitness to Drive driving simulator score
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
The Test Ride for Investigating Practical Fitness to Drive is a structured driving simulator assessment developed to evaluate the practical fitness to drive of older adults and individuals with medical conditions.
Total items are 49 scored on an ordinal scale of 1-4.
Total score is 196.
A higher score indicates better driving performance.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Driving aptitude - Driver Comfort Questionnaire
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
The Driver Comfort Questionnaire is a self-report questionnaire designed to assess how comfortable and confident individuals feel in different driving situations.
It is scored between 0 and 100 percent.
A higher score indicates a higher comfort level of driving.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
|
Driving aptitude - Driving and Riding Avoidance Scale
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
The Driving and Riding Avoidance Scale is a questionnaire that measures the extent to which individuals avoid certain driving or riding situations due to discomfort, anxiety, or reduced confidence.
There are 20 items in this questionnaire.
Each item is scored 0-4.
A lower score indicates less avoidance behavior.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily Driving Log
Time Frame: Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
A self-reported Daily Driving Log, manually entered in a journal by each participant, will be collected to analyze driving patterns during the study period.
|
Baseline (pre-intervention) and at 4 weeks (post-intervention)
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, Agid Y, DeLong MR, Obeso JA. Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nat Rev Neurosci. 2010 Nov;11(11):760-72. doi: 10.1038/nrn2915. Epub 2010 Oct 14.
- Meindorfner C, Korner Y, Moller JC, Stiasny-Kolster K, Oertel WH, Kruger HP. Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord. 2005 Jul;20(7):832-42. doi: 10.1002/mds.20412.
- Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007 Jan 30;68(5):384-6. doi: 10.1212/01.wnl.0000247740.47667.03. Epub 2006 Nov 2.
- Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014 Nov;29(13):1583-90. doi: 10.1002/mds.25945. Epub 2014 Jun 28.
- Akinwuntan AE, De Weerdt W, Feys H, Pauwels J, Baten G, Arno P, Kiekens C. Effect of simulator training on driving after stroke: a randomized controlled trial. Neurology. 2005 Sep 27;65(6):843-50. doi: 10.1212/01.wnl.0000171749.71919.fa.
- Devos H, Vandenberghe W, Nieuwboer A, Tant M, Baten G, De Weerdt W. Predictors of fitness to drive in people with Parkinson disease. Neurology. 2007 Oct 2;69(14):1434-41. doi: 10.1212/01.wnl.0000277640.58685.fc.
- Wood JM, Worringham C, Kerr G, Mallon K, Silburn P. Quantitative assessment of driving performance in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):176-80. doi: 10.1136/jnnp.2004.047118.
- Uc EY, Rizzo M, Anderson SW, Dastrup E, Sparks JD, Dawson JD. Driving under low-contrast visibility conditions in Parkinson disease. Neurology. 2009 Oct 6;73(14):1103-10. doi: 10.1212/WNL.0b013e3181bacf6e.
- Stolwyk RJ, Triggs TJ, Charlton JL, Iansek R, Bradshaw JL. Impact of internal versus external cueing on driving performance in people with Parkinson's disease. Mov Disord. 2005 Jul;20(7):846-57. doi: 10.1002/mds.20420.
- Brock P, Oates LL, Gray WK, Henderson EJ, Mann H, Haunton VJ, Skelly R, Hand A, Davies ML, Walker RW. Driving and Parkinson's Disease: A Survey of the Patient's Perspective. J Parkinsons Dis. 2022;12(1):465-471. doi: 10.3233/JPD-212686.
- Collia DV, Sharp J, Giesbrecht L. The 2001 National Household Travel Survey: a look into the travel patterns of older Americans. J Safety Res. 2003;34(4):461-70. doi: 10.1016/j.jsr.2003.10.001.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- STUDY00161777
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease (PD)
-
EicOsis Human Health Inc.University of California, Davis; Michael J. Fox Foundation for Parkinson's...RecruitingParkinson's Disease (PD)United States
-
University Hospital Schleswig-HolsteinUniversity of Kiel; University of Cologne; University Hospital, Bonn; Philipps...Not yet recruitingParkinson's Disease (PD)
-
Guangzhou Henovcom Bioscience Co. Ltd.Frontage Clinical Services, Inc.Active, not recruitingParkinson's Disease (PD)United States
-
Universitätsklinikum Hamburg-EppendorfUniversity of Oxford; University of TwenteRecruitingDeep Brain Stimulation | Parkinson's Disease (PD)Germany
-
Ege UniversityCompletedDysphagia | Parkinson's Disease (PD)Turkey (Türkiye)
-
University of FloridaCompletedParkinson Disease (PD)United States
-
Riphah International UniversityNot yet recruitingParkinson's Disease (PD)Pakistan
-
Zhang JianguoNot yet recruitingPD - Parkinson's DiseaseChina
-
Fujita Health UniversityRecruitingParkinson's Disease (PD)Japan
-
Chang Gung Memorial HospitalChang Gung UniversityRecruitingAging | Parkinson's Disease (PD)Taiwan
Clinical Trials on Low-fidelity driving simulator training
-
University of Kansas Medical CenterRecruitingStroke | Multiple Sclerosis | Parkinson DiseaseUnited States
-
Aydin Adnan Menderes UniversityActive, not recruitingOstomy | Nursing Students | Simulation-based LearningTurkey
-
Rigshospitalet, DenmarkCompleted
-
Aarhus University HospitalWithdrawnPulmonary Disease, Chronic ObstructiveDenmark
-
PSA Automobiles S.A.University of Bordeaux; University Hospital, BordeauxCompletedHealthy Subjects | Attention DeficitFrance
-
Saglik Bilimleri UniversitesiNot yet recruitingCardiopulmonary Resuscitation | Nursing CariesTurkey
-
National Taiwan University HospitalUnknown
-
Zonguldak Bulent Ecevit UniversityNurten Taşdemir Assoc. Prof. PhD.UnknownCardiopulmonary Resuscitation | Nurse's Role | Simulation TrainingTurkey